Skip to main content
. 2020 May 18;66(2):201–209. doi: 10.5606/tftrd.2020.4192

Table 4. Pain, depression, and functional disability according to study groups.

  Physical therapy †p ‡p
  Group 1 (n=26) †p Group 2 (n=27)    
  Mean±SD Median Min-Max   Mean±SD Median Min-Max      
Visual analog scale                  
Pre-treatment 7.2±1.7 7,5 3-9   7.0±1.4 7 4-9   0,377
Post-treatment 5.0±1.5 5 2-7   3.7±1.5 4 1-6   0.002**
Week 4 (EOT) 3.3±1.4 3 1-6   2.0±1.3 2 0-5   0.002**
§p   0.001**       0.001**      
Difference                  
Pre-/post-treatment -2.2±0.6 -2   0.001** -3.3±0.9 -3   0.001** 0.001**
Pre-treatment/week 4 (EOT) -3.9±1.1 -4   0.001** -5.0±1.0 -5   0.001** 0.001**
Post-treatment/week 4 (EOT) -1.7±0.7 -2   0.001** -1.6±0.6 -2   0.001** 0,529
Beck Depression Inventory                  
Pre-treatment 12.0±7.4 12 1-29   12.0±4.4 12 2-20   0,506
Post-treatment 9.4±6.4 8 0-22   7.3±3.9 7 1-16   0,304
Week 4 (EOT) 6.5±5.0 6 0-18   4.6±3.6 4 0-13   0,139
§p   0.001**       0.001**      
Difference                  
Pre-/post-treatment -2.6±2.1 -2   0.001** -4.7±2.5 -4   0.001** 0.001**
Pre-treatment/week 4 (EOT) -5.5±3.1 -5   0.001** -7.4±3.1 -8   0.001** 0.014*
Post-treatment/week 4 (EOT) -2.9±1.8 -2,5   0.001** -2.7±2.9 -3   0.001** 0,612
Oswestry Disability Index                
Pre-treatment 36.2±18.6 33 4-72   35.9±14.3 36 8-56   0,950
Post-treatment 27.1±16.1 23 2-56   20.7±11. 6 16 2-44   0,104
Week 4 (EOT) 17.8±12.4 16 0-44   12.2±10.7 8 0-40   0.032*
§p   0.001**       0.001**      
Difference                  
Pre-/post-treatment -9.2±4.7 -8   0.001** -15.2±6.6 -14   0.001** 0.001**
Pre-treatment/week 4 (EOT) -18.5±9.1 -19   0.001** -23.7±9.7 -24   0.001** 0.041*
Post-treatment/week 4 (EOT) -9.3±5.5 -8   0.001** -8.5±4.5 -8   0.001** 0,690
SD: Standard deviation; EOT: End of treatment; * p<0.05; ** p<0.01; † Wilcoxon signed-rank test; ‡ Mann-Whitney U test; § Friedman test.